Combination of sulphasalazine and methotrexate versus the single components in early rheumatoid arthritis: A randomized, controlled, double-blind, 52 week clinical trial

British Journal of Rheumatology

Volumn 36, Issue 10, 1997, Pages 1082-1088

  Haagsma, C J ^a   Van Riel, P L C M ^b   De Jong, A J L ^b   Van De Putte, L B A ^b  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b NONE

Author keywords

Combination therapy; Early rheumatoid arthritis; Methotrexate; Sulphasalazine

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; HLA DR1 ANTIGEN; HLA DR4 ANTIGEN; METHOTREXATE; RHEUMATOID FACTOR; SALAZOSULFAPYRIDINE;

ABDOMINAL PAIN; ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ACTIVITY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; DYSPNEA; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; FLU LIKE SYNDROME; HEADACHE; HEARTBURN; HUMAN; MAJOR CLINICAL STUDY; MALE; NAUSEA; NEUROPATHY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RASH; RHEUMATOID ARTHRITIS; STOMATITIS; VERTIGO;

EID: 0030696346     PISSN: 02637103     EISSN: None     Source Type: Journal    
DOI: 10.1093/rheumatology/36.10.1082     Document Type: Article

References (20)

1. Van der Heijde DMFM, van Leeuwen MA, van Riel PLCM et al. Biannual radiographic assessment of hands and feet in a three-year prospective follow-up of patients with early rheumatoid arthritis. Arthritis Rheum 1992;35:26-34.
2. Harris ED. Rheumatoid arthritis. Pathophysiology and implications for therapy. N Engl J Med 1990;322:1277-89.
3. Paulus HE. The use of combinations of disease modifying antirheumatic agents in rheumatoid arthritis. Arthritis Rheum 1990;33:113-20.
4. Huskisson EC. Combination chemotherapy of rheumatoid arthritis. Br J Rheumatol 1987;26:243-4.
5. Klippel JH. Winning the battle, losing the war? Another editorial about rheumatoid arthritis. J Rheumatol 1990;17:1118-22.
6. Boers M, Ramsden M. Longacting drug combinations in rheumatoid arthritis: a formal overview. J Rheumatol 1991;18:316-24.
7. Felson DT, Anderson JJ, Meenan RF. Use of short- term efficacy/toxicity tradeoffs to select second-line drugs in rheumatoid arthritis. A metanalysis of published trials. Arthritis Rheum 1992;35:1117-25.
8. Jeurissen MEC, Boerbooms AMTh, van de Putte LBA et al. Methotrexate versus azathioprine in the treatment of rheumatoid arthritis: a forty-eight-week randomized double-blind trial. Arthritis Rheum 1991;34:961-73.
9. Haagsma CJ, van de Putte LBA, van Riel PLCM. Combining sulphasalazine and methotrexate in rheumatoid arthritis: early clinical impressions. Br J Rheumatol 1995;34(suppl. 2):104-8.
10. Van der Heijde DMFM, van't Hoff MA, van Riel PLCM, Theunisse LAM, Lubberts EW, van Leeuwen MA et al. Judging disease activity in clinical practice in rheumatoid arthritis: first step in the development of a disease activity score. Ann Rheum Dis 1990;49:916-20.
11. Van Gestel AM, Prevoo MLL, van't Hoff MA, van Rijswijk MH, van de Putte LBA, van Riel PLCM. Development and validation of the European League Against Rheumatism response criteria for rheumatoid arthritis: Comparison with the preliminary American College of Rheumatology and the World Health Organisation/International League Against Rheumatism Criteria. Arthritis Rheum 1996;39:34-40.
12. Richie DM, Boyle JA, McInness JM et al. Clinical studies with an articular index for the assessment of joint tenderness in patients with rheumatoid arthritis. Q J Med 1968;147:393-406.
13. Felson DT, Anderson JJ, Boers M et al. American College of Rheumatology preliminary definition of improvement in rheumatoid arthritis. Arthritis Rheum 1995;38:727-35.
14. Goodman SN, Berlin JA. The use of predicted confidence intervals when planning experiments and the misuse of power when interpreting results. Ann Intern Med 1994;121:200-6.
15. Healey LA, Wilske KR. Reforming the pyramid. A plan for treating rheumatoid arthritis in the 1990s. Rheum Dis Clin North Am 1989;15:615-9.
16. Haagsma CJ, van Riel PLCM, van de Putte LBA. Combination of methotrexate and sulphasalazine versus methotrexate alone. A randomized open clinical trial in rheumatoid arthritis patients resistant to sulphasalazine therapy. Br J Rheumatol 1994;33:1049-55.
17. Refsum H, Helland S, Ueland PM. Fasting plasma homocysteine as a sensitive parameter of antifolate effect: A study of psoriasis patients receiving low-dose methotrexate treatment. Clin Pharmacol Ther 1989;46:510-20.
18. Selhub J, Dhar GJ, Rosenberg IH. Inhibition of folate enzymes by sulfasalazine. J Clin Invest 1978;61:221-4.
19. O'Dell JR, Haire CE, Erikson N et al. Treatment of rheumatoid arthritis with methotrexate alone, sulfasalazine and hydroxychloroquine, or a combination of all three medications. N Engl J Med 1996;334:1287-91.
20. Weinblatt ME, Kaplan H, Germain BF. Methotrexate in rheumatoid arthritis. A five-year prospective multicenter study. Arthritis Rheum 1994;37:1492-8.